These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4031386)

  • 1. More on nomifensine.
    Liuzzi A; Chiodini PG
    J Endocrinol Invest; 1985 Apr; 8(2):183-4. PubMed ID: 4031386
    [No Abstract]   [Full Text] [Related]  

  • 2. Nomifensine in hyperprolactinemic states.
    Müller EE; Camanni F; Genazzani AR
    J Endocrinol Invest; 1984 Aug; 7(4):421. PubMed ID: 6438225
    [No Abstract]   [Full Text] [Related]  

  • 3. Nomifensine test for investigation of hyperprolactinaemia.
    Dunne MJ; Walker J; Cowden EA; Ratcliffe JG
    Lancet; 1979 Dec; 2(8154):1243. PubMed ID: 92650
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolactin responsiveness to nomifensine in patients with hyperprolactinemia of tumorous or uncertain etiology.
    Camanni F; Genazzani AR; Massara F; de Leo V; Molinatti GM; Müller EE
    J Clin Endocrinol Metab; 1980 Sep; 51(3):650-3. PubMed ID: 7410539
    [No Abstract]   [Full Text] [Related]  

  • 5. Cortisol secretion following nomifensine administration in normal subjects.
    Alagna S; Masala A
    Biomedicine; 1979 Nov; 31(7):189-91. PubMed ID: 526541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomifensine-induced pregnancy in a hyperprolactinemic woman.
    Genazzani AR; De Leo V; Camanni F; Müller EE
    J Endocrinol Invest; 1982; 5(2):129-30. PubMed ID: 7096920
    [No Abstract]   [Full Text] [Related]  

  • 7. Nomifensine: diagnostic test in hyperprolactinemic states.
    Müller EE; Genazzani AR; Murru S
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1352-7. PubMed ID: 263356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approach to the diagnosis of hyperprolactinemic states: the nomifensine and domperidone tests.
    Molinatti GM; Camanni F; Cocchi D; De Leo V; Genazzni AR; Massara F; Muller EE
    Panminerva Med; 1981; 23(1):5-10. PubMed ID: 7290727
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure of nomifensine to reduce serum prolactin levels in patients with hepatic encephalopathy.
    Masala A; Alagna S; Rovasio PP; Deplano A; Anania V; Chiandussi L; Langer M
    J Endocrinol Invest; 1985 Feb; 8(1):25-9. PubMed ID: 3921593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomifensine in the diagnosis of hyperprolactinemia.
    Gullo D; Carmina E; Mogavero G; Perino A; Venezia R
    Acta Eur Fertil; 1981 Dec; 12(4):299-306. PubMed ID: 7342611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a dopaminergic drug on LH, FSH and prolactin levels in PCO syndrome.
    Venturini PL; Alibrandi MP; Costantini S; Gaggero G; Penna L; Valenzano M; Ragni N
    Acta Eur Fertil; 1981 Sep; 12(3):295-7. PubMed ID: 6803505
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacodynamics of nomifensine: a review of studies in healthy subjects.
    Siegfried K; Taeuber K
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):33-8. PubMed ID: 6370972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of nomifensine on prolactin secretion in patients with suspected pituitary microadenoma.
    Jeske W; Stopińska U
    Endokrynol Pol; 1981; 32(1):17-24. PubMed ID: 7250073
    [No Abstract]   [Full Text] [Related]  

  • 14. Nomifensine, TRH and insulin-induced hypoglycemia tests in the diagnosis of prolactinomas.
    Iannotta F; Fachinetti P; Fachinetti A; Pinotti G; Usellini L
    J Endocrinol Invest; 1983 Oct; 6(5):353-8. PubMed ID: 6420458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors.
    Kamoi K; Tchuchida I; Sato H; Tanaka R; Ishiguro T; Kaneko K; Iwasaki Y; Shibata A
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1285-7. PubMed ID: 7298805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nomifensine on growth hormone and prolactin secretion in normal subjects and in pathological hyperprolactinemia.
    Dallabonzana D; Spelta B; Botalla L; Oppizzi G; Silvestrini F; Chiodini PG; Liuzzi A
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1125-8. PubMed ID: 7076795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentric experience on the acute effect of nomifensine in hyperprolactinemic women.
    Minuto F; Barbarino A; Baviera G; Mazzocchi G; De Marinis L; Leonardi R; Bernasconi D; Menini E; Maira G; Anile C
    J Endocrinol Invest; 1984 Apr; 7(2):137-40. PubMed ID: 6725869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of nomifensine administration to discriminate between tumorous and nontumorous hyperprolactinemia.
    Ferrari C; Crosignani PG; Caldara R; Picciotti MC; Malinverni A; Barattini B; Rampini P; Telloli P
    J Clin Endocrinol Metab; 1980 Jan; 50(1):23-6. PubMed ID: 7188615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced alterations of the hypothalamus-hypophysis axis.
    Mazzi C; Riva LP; Morandi G; Mainini E; Martinelli I; Bertaccini G
    Acta Psychiatr Belg; 1980; 80(5):619-37. PubMed ID: 7234453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of antidepressants on the secretion of pituitary hormones in healthy subjects, neurotic depressive patients and endogenous depressive patients (author's transl)].
    Laakmann G
    Nervenarzt; 1980; 51(12):725-32. PubMed ID: 7207684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.